ClinicalTrials.Veeva

Menu

Drug Concentration and Volume on Adequate Labor Analgesia With PIEB (CADD2)

Northwestern University logo

Northwestern University

Status and phase

Terminated
Phase 4

Conditions

Labor Pain
Pain
Anesthesia

Treatments

Drug: Low volume bolus
Drug: High volume bolus

Study type

Interventional

Funder types

Other

Identifiers

NCT03553576
STU00206113

Details and patient eligibility

About

Neuraxial labor analgesia is performed by the administration of a local anesthetic/opioid mixture in the epidural space. The delivery method is a combination of continuous infusion, provider-administered boluses and patient-administered boluses (patient controlled epidural analgesia [PCEA]) via epidural catheter. The anesthetic solution administered through the lumbar epidural catheter must spread cephalad in the epidural space to reach the T10 nerve roots and spinal cord, and must spread caudad to reach the caudal nerve roots in the epidural space.

Epidural infusion pumps capable of delivering PIEB of local anesthetic with PCEA have become commercially available and many studies have attempted to assess the optimal parameter settings (including volume of programmed bolus, bolus interval, rate of bolus administration) to provide superior labor analgesia.

Traditionally higher concentration local anesthetic solutions have been associated with increased motor blockade leading to a higher incidence of instrumental vaginal delivery. Several local anesthetic solutions with varying drug concentrations are available for labor analgesia and are used clinically in the United States. We plan to perform a randomized, controlled, double-blind study to test the hypothesis that patients whose labor analgesia is maintained using PIEB with low-volume bolus (6.25 mL) of a higher local anesthetic concentration solution (0.1% bupivacaine with fentanyl 2.0 mcg/mL) will require less supplemental analgesia (manual provider re-doses) than patients whose PIEB is delivered with a high-volume bolus (10 mL) of lower density local anesthetic solution (0.0625% bupivacaine with fentanyl 2.0 mcg/mL).

The aim of this study is to evaluate the association between bolus volume and concentration of local anesthetic during maintenance of labor analgesia with programmed intermittent epidural bolus (PIEB) analgesia.

The hypothesis of this study is: patients whose labor analgesia is maintained using PIEB with low-volume bolus (6.25 mL) of higher local anesthetic concentration solution (0.1% bupivacaine with fentanyl 2.0 mcg/mL) will have a longer duration of adequate analgesia (time to first manual re-dose request) than patients whose PIEB is delivered with a high-volume bolus (10 mL) of lower concentration local anesthetic solution (0.0625% bupivacaine with fentanyl 2.0 mcg/mL).

Enrollment

146 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years and above
  • Nulliparous parturients
  • Present to the labor and delivery unit for an induction of labor or who are in spontaneous labor
  • Request neuraxial labor analgesia at ≤5 cm cervical dilation

Exclusion criteria

  • Patients who are not eligible to receive a combined spinal epidural (CSE) technique with 25 mcg of intrathecal fentanyl
  • Non-English speaking
  • Failed initiation of CSE analgesia (VAS pain score >10 15 minutes after intrathecal dose)
  • Need to have the epidural catheter replaced during labor
  • Who deliver within 90 minutes of initiation of labor analgesia
  • Require re-dose within 90 minutes of initiation of labor analgesia.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

146 participants in 2 patient groups

Low volume bolus
Experimental group
Description:
6.25 mL administration at 250 ml per hour of a greater density solution (0.1% bupivacaine with fentanyl 2.0 mcg/mL)
Treatment:
Drug: Low volume bolus
High volume bolus
Experimental group
Description:
10 mL administration of a lower density local anesthetic (0.0625% bupivacaine with fentanyl 2.0 mcg/mL).
Treatment:
Drug: High volume bolus

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Paul C Fitzgerald, MS; Feyce Perlata, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems